Evidence map›Paper›PMID 31554420›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2019

Copper Transporter ATP7A (Copper-Transporting P-Type ATPase/Menkes ATPase) Limits Vascular Inflammation and Aortic Aneurysm Development: Role of MicroRNA-125b.

Varadarajan Sudhahar, Archita Das, Tetsuo Horimatsu, Dipankar Ash, Silvia Leanhart, Olga Antipova, Stefan Vogt, Bhupesh Singla, Gabor Csanyi, Joseph White and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. The Yin and Yang of copper in cardiovascular health and disease.Molecular and cellular biochemistry · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  14. Article
  15. Article
  16. The Role of Copper Homeostasis in Brain Disease.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Varadarajan SudhaharFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Archita DasFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Tetsuo HorimatsuFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Dipankar AshFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Silvia LeanhartFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Olga AntipovaX-ray Science Division, Argonne National Laboratory, IL (O.A., S.V.).
Stefan VogtX-ray Science Division, Argonne National Laboratory, IL (O.A., S.V.).
Bhupesh SinglaFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Gabor CsanyiFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Joseph WhiteDepartment of Pathology (J.W.), Medical College of Georgia at Augusta University, GA.
Jack H KaplanDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago (J.H.K.).
David FultonFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Neal L WeintraubFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Ha Won KimFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Masuko Ushio-FukaiFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Tohru FukaiFrom the Vascular Biology Center (V.S., A.D., T.H., D.A., S.L., B.S., G.C., D.F., N.L.W., H.W.K., M.U.-F., T.F.), Medical College of Georgia at Augusta University, GA.
Augusta University · USUniversity of Illinois Chicago · US

Funding

Vascular Extracellular Superoxide Dismutase ModulationR01HL070187 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FUKAI, TOHRU · 2002 to 2017
$4.2M
Copper transport protein and inflammatory angiogenesisR01HL116976 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FUKAI, TOHRU, USHIO-FUKAI, MASUKO · 2013 to 2016
$2.9M
Cu Transporting ATPase and Diabetic Vascular ComplicationsR01HL133613 · NHLBI · AUGUSTA UNIVERSITY · PI FUKAI, TOHRU, USHIO-FUKAI, MASUKO · 2017 to 2020
$2.7M
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle ProgenitorsR01AR070029 · NIAMS · AUGUSTA UNIVERSITY · PI ASHRAF, MUHAMMAD, TANG, YAO LIANG · 2016 to 2021
$2.6M
Notch1/miR-322 Axis in Stem Cell Mediated Vascular RepairR01HL134354 · NHLBI · AUGUSTA UNIVERSITY · PI ASHRAF, MUHAMMAD, TANG, YAO LIANG · 2016 to 2020
$2.5M
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysmR01HL142097 · NHLBI · AUGUSTA UNIVERSITY · PI WEINTRAUB, NEAL L · 2018 to 2021
$2.1M
Lipid macropinocytosis: a novel target in atherosclerotic cardiovascular diseaseR01HL139562 · NHLBI · AUGUSTA UNIVERSITY · PI CSANYI, GABOR · 2018 to 2022
$1.9M
Epigenetic regulation of HDAC9 in obesity and atherosclerosisR01HL126949 · NHLBI · AUGUSTA UNIVERSITY · PI WEINTRAUB, NEAL L · 2016 to 2019
$1.8M
Protein Disulfide Isomerase as Novel Redox Sensor in VEGF SignalingR01HL135584 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI USHIO-FUKAI, MASUKO · 2017 to 2020
$1.5M
SUMOylation of Cu transport protein Atox1 in AtherosclerosisI01BX001232 · VA · JESSE BROWN VA MEDICAL CENTER · PI TOHRU FUKAI · 2012 to 2026
–
BLRD VA I01 BX001232NHLBI NIH HHS R01 HL070187NHLBI NIH HHS R01 HL116976NHLBI NIH HHS R01 HL126949NHLBI NIH HHS R01 HL133613NHLBI NIH HHS R01 HL134354NHLBI NIH HHS R01 HL135584NHLBI NIH HHS R01 HL142097NIAMS NIH HHS R01 AR070029
6 · The paper itself

Abstract

objectiveCopper (Cu) is essential micronutrient, and its dysregulation is implicated in aortic aneurysm (AA) development. The Cu exporter ATP7A (copper-transporting P-type ATPase/Menkes ATPase) delivers Cu via the Cu chaperone Atox1 (antioxidant 1) to secretory Cu enzymes, such as lysyl oxidase, and excludes excess Cu. Lysyl oxidase is shown to protect against AA formation. However, the role and mechanism of ATP7A in AA pathogenesis remain unknown. Approach and Results: Here, we show that Cu chelator markedly inhibited Ang II (angiotensin II)-induced abdominal AA (AAA) in which ATP7A expression was markedly downregulated. Transgenic ATP7A overexpression prevented Ang II-induced AAA formation. Conversely, Cu transport dysfunctional ATP7A

conclusionsATP7A downregulation/dysfunction promotes AAA formation via upregulating miR-125b, which augments proinflammatory signaling in a Cu-dependent manner. Thus, ATP7A is a potential therapeutic target for inflammatory vascular disease.

Indexed as

Angiotensin IIAnimalsAortic Aneurysm, AbdominalApoptosisCells, CulturedChelating AgentsCopperCopper-Transporting ATPasesCopper Transport ProteinsDisease Models, AnimalDown-RegulationFemaleHumansInflammationMaleMice, Inbred C57BLAngiotensin IIAtox1 protein, mouseATP7A protein, humanAtp7a protein, mouseChelating AgentsCopperCopper-Transporting ATPasesCopper Transport ProteinsMicroRNAsMIRN125 microRNA, humanMirn125 microRNA, mouseMolecular ChaperonesMolybdenumtetrathiomolybdateangiotensin IIaortic aneurysmcopperelastinmicronutrient

Identifiers

PMID31554420
PMCPMC6857803
OpenAlexW2981918029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.